UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$205M |
| 2 |
Johnson & Johnson
JNJ
|
+$186M |
| 3 |
Honeywell
HON
|
+$177M |
| 4 |
Mondelez International
MDLZ
|
+$132M |
| 5 |
Alibaba
BABA
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$270M |
| 2 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$212M |
| 3 |
Citigroup
C
|
+$185M |
| 4 |
Booking.com
BKNG
|
+$104M |
| 5 |
Intuitive Surgical
ISRG
|
+$103M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.89% |
| 2 | Technology | 14.47% |
| 3 | Financials | 12.9% |
| 4 | Consumer Discretionary | 10.06% |
| 5 | Communication Services | 8.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRC
626
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $20.5M | 0.02% |
358,393
+26,963
| +8% | +$1.41M |
|
627
Fortune Brands Innovations
FBIN
$6.11B
| $20.5M | 0.02% |
413,425
+11,415
| +3% | +$557K |
|
628
NiSource
NI
$21.4B
| $20.4M | 0.02% |
771,107
+461,782
| +149% | +$11.1M |
|
629
Unum
UNM
$14.3B
| $20.4M | 0.02% |
640,515
+3,937
| +0.6% | +$133K |
|
|
KITE
630
DELISTED
Kite Pharma, Inc.
KITE
| $20.4M | 0.02% |
407,236
+29,658
| +8% | +$1.46M |
|
|
SRCL
631
DELISTED
Stericycle Inc
SRCL
| $20.3M | 0.02% |
194,980
-50,794
| -21% | -$5.43M |
|
632
SiriusXM
SIRI
$10.3B
| $20.3M | 0.02% |
513,841
+1,773
| +0.3% | +$69.7K |
|
633
Jazz Pharmaceuticals
JAZZ
$15.8B
| $20.3M | 0.02% |
143,600
-1,659
| -1% | -$245K |
|
|
FLTX
634
DELISTED
Fleetmatics Group PLC
FLTX
| $20.1M | 0.02% |
462,863
-227,732
| -33% | -$9.08M |
|
635
Alaska Air
ALK
$5.52B
| $19.9M | 0.02% |
342,066
+32,806
| +11% | +$2.27M |
|
636
Seagate
STX
$187B
| $19.9M | 0.02% |
817,634
+22,263
| +3% | +$540K |
|
637
Imperial Oil
IMO
$61.1B
| $19.8M | 0.02% |
627,866
+8,256
| +1% | +$261K |
|
|
CMA
638
DELISTED
Comerica
CMA
| $19.7M | 0.02% |
479,665
-142,203
| -23% | -$6.06M |
|
|
ICPT
639
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $19.7M | 0.02% |
138,117
-4,468
| -3% | -$651K |
|
640
Kinross Gold
KGC
$27.5B
| $19.6M | 0.02% |
4,020,579
-935,640
| -19% | -$4.46M |
|
|
CDK
641
DELISTED
CDK Global, Inc.
CDK
| $19.6M | 0.02% |
352,994
+13,069
| +4% | +$675K |
|
|
WCN
642
Waste Connections
WCN
$42.2B
| $19.5M | 0.02% |
406,628
+5,421
| +1% | +$247K |
|
643
CBRE Group
CBRE
$42.4B
| $19.4M | 0.02% |
733,410
+39,554
| +6% | +$1.16M |
|
|
IFLN
644
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
$305M
| – | – |
0
| – | – |
|
645
Emergent Biosolutions
EBS
$375M
| $19.3M | 0.02% |
685,800
+370,847
| +118% | +$14.5M |
|
646
United Rentals
URI
$68.9B
| $19.3M | 0.02% |
287,230
-974,578
| -77% | -$63.6M |
|
|
AMTD
647
DELISTED
TD Ameritrade Holding Corp
AMTD
| $19.2M | 0.02% |
675,284
+93,777
| +16% | +$2.85M |
|
648
Xylem
XYL
$27.7B
| $19.2M | 0.02% |
429,527
-177
| -0% | -$7.69K |
|
649
Arthur J. Gallagher & Co
AJG
$63.8B
| $19.1M | 0.02% |
401,721
+17,496
| +5% | +$812K |
|
650
NetApp
NTAP
$35.8B
| $19.1M | 0.02% |
777,185
+19,843
| +3% | +$489K |
|
Similar funds
UBS AM's Q2 2016 Portfolio in Review
As of Q2 2016, UBS AM held 2,695 positions worth $88.5B, up 2.6% from $86.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q2 2016 filing shows 65 new, 1,198 increased, 577 reduced and 89 closed positions. Its largest new stake was S&P Global: 1,914,020 shares worth $205M. The largest sale was MCGRAW-HILL FINANCIAL INC COM, an estimated $270M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q2 2016 buy was S&P Global: 1,914,020 shares worth $205M.
- UBS AM added most to Johnson & Johnson in Q2 2016, an estimated $186M increase.
- UBS AM's biggest Q2 2016 reduction was Citigroup, cutting an estimated $185M.
- UBS AM fully exited MCGRAW-HILL FINANCIAL INC COM in Q2 2016, selling an estimated $270M.
- UBS AM's ten largest holdings make up 14% of its $88.5B portfolio in Q2 2016.
- UBS AM opened 65 new positions and closed 89 in Q2 2016.
- UBS AM's portfolio value rose 2.6% quarter-over-quarter to $88.5B.
Based on UBS AM's 13F filing for Q2 2016, filed 9 Aug 2016.